summary
Introduced
02/14/2023
02/14/2023
In Committee
03/13/2023
03/13/2023
Crossed Over
Passed
Dead
01/03/2025
01/03/2025
Introduced Session
118th Congress
Bill Summary
A BILL To direct the Secretary of Veterans Affairs to carry out a study and clinical trials on the effects of cannabis on certain health outcomes of veterans with chronic pain and post-traumatic stress disorder, and for other purposes.
AI Summary
This bill, the VA Medicinal Cannabis Research Act of 2023, directs the Secretary of Veterans Affairs (VA) to carry out a large-scale, mixed methods, retrospective, and qualitative study on the effects of cannabis on the health outcomes of veterans with chronic pain and post-traumatic stress disorder (PTSD). If the Secretary determines that the VA can meet the necessary criteria, the bill also requires the Secretary to conduct a series of clinical trials on the effects of cannabis on the health outcomes of these veterans. The bill specifies the elements and health outcomes to be evaluated in the study and trials, and requires periodic and final reports to Congress on the implementation of the study and trials.
Committee Categories
Health and Social Services, Military Affairs and Security
Sponsors (12)
Lou Correa (D)*,
Jack Bergman (R),
Earl Blumenauer (D),
Jasmine Crockett (D),
Jason Crow (D),
Chris Deluzio (D),
Maxwell Frost (D),
Val Hoyle (D),
Dan Kildee (D),
Zoe Lofgren (D),
Nancy Mace (R),
Seth Moulton (D),
Last Action
Referred to the Subcommittee on Health. (on 03/13/2023)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/118th-congress/house-bill/1003/all-info |
| BillText | https://www.congress.gov/118/bills/hr1003/BILLS-118hr1003ih.pdf |
Loading...